Fibrodysplasia ossificans progressiva. A survey of forty-two cases

Insights

Fibrodysplasia ossificans progressiva (FOP) in children is recognizable at birth with toe and thumb abnormalities. Early diagnosis of FOP is crucial to prevent injury-induced bone formation and manage physical disability.

Area of Science:

  • Medical Genetics
  • Pediatric Orthopedics
  • Rare Diseases

Background:

  • Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by progressive heterotopic ossification.
  • Congenital malformations, including hallux valgus and short thumbs, are key indicators in newborns.
  • Delayed diagnosis is common, hindering timely interventions and management.

Purpose of the Study:

  • To highlight the importance of early recognition of FOP in pediatric patients.
  • To emphasize the need for protective measures against injuries that can trigger ossification.
  • To discuss the genetic basis and current treatment considerations for FOP.

Main Methods:

  • Clinical observation of pediatric patients with FOP.
  • Review of diagnostic criteria and congenital anomalies.
  • Analysis of disease progression and impact of injuries.

Main Results:

  • Characteristic congenital abnormalities, such as shortened great toe and short thumbs, aid in early diagnosis.
  • Most FOP cases manifest symptoms by age four, but diagnosis is often delayed.
  • Injuries can exacerbate FOP by initiating new bone formation.
  • The axial skeleton is the primary site of onset and greatest involvement.
  • Disodium etidronate (EHDP) has not yet demonstrated proven value in most patients.
  • Evidence suggests most FOP cases result from dominant mutations.

Conclusions:

  • Early identification of FOP is critical for preventing trauma-induced heterotopic ossification.
  • Avoidance of biopsy and surgery is recommended due to potential complications.
  • Most FOP cases appear to arise from new dominant mutations, impacting genetic counseling.

Related Concept Videos